The Therapeutic Goods Administration (TGA) has provisionally approved two oral antiviral treatments for COVID-19. Here’s what pharmacists need to know.

Pharmacists discuss the impressive results of the Take Home Naloxone Pilot and why subsidised access to the medicine is a must going forward.

Pronouns are words used to refer toa person and contribute to a person’s gender identity. They can develop and change over time and can be gender specific (e.g. she/her/hers or he/him/his) or gender neutral (e.g. they/them/theirs or ze/hir/hirs).

This month Amanda Fairjones, Professional Support Advisor, and Peter Guthrey, Senior Pharmacist answer your questions about COVID-19 vaccine requirements and the new nicotine vaping guidelines.

Pharmacists’ accessibility and expertise make them an essential part of severe allergy management in children.

Pharmacists working in aged care can help providers recognise chemical restraint, recommend alternative strategies before use, and ensure timely monitoring and review.

Antimicrobial use has declined dramatically in Australia during the pandemic, but the figures show there is no room for complacency.

More than 250,000 Australians have faulty heart valves and are at risk of serious complications, including heart failure, stroke and death – yet don’t know it. Australian Pharmacist spoke to an expert about the symptoms pharmacists should be aware of.

A new Pharmaceutical Benefits Scheme listing last week for dry eye product Cationorm ties into a quirky review of a new area of literature from United States researchers. 

This month, we’ll again focus on COVID-19 vaccination questions answered by Amanda Fairjones, Professional Support Advisor.